In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

Research output: Contribution to journalArticle

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{04842bffb4924a6cb5f387152228df65,
title = "In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]",
author = "John Gordon and Nicholas Barnes and Elisabeth Meredith and Mark Drayson",
year = "2008",
month = mar
day = "15",
doi = "10.1016/J.BCP.2008.02.009",
language = "English",
volume = "75",
pages = "e1--e3",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier",
number = "6",

}

RIS

TY - JOUR

T1 - In response to “Selective serotonin reuptake inhibitors—A new modality for the treatment of lymphoma/leukaemia?” by C. Schuster, et al. [Biochem. Pharmacol. 74 (9) 2007 1424–1435]

AU - Gordon, John

AU - Barnes, Nicholas

AU - Meredith, Elisabeth

AU - Drayson, Mark

PY - 2008/3/15

Y1 - 2008/3/15

U2 - 10.1016/J.BCP.2008.02.009

DO - 10.1016/J.BCP.2008.02.009

M3 - Article

C2 - 18319082

VL - 75

SP - e1-e3

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 6

ER -